News On Japan

Japan approves coronavirus vaccine aimed at Omicron

Sep 13, 2022 (NHK) - Japan has approved the use of coronavirus vaccines that target Omicron for people aged 12 or older who have received their first two shots.

The so-called bivalent vaccines, made by US drug makers Pfizer and Moderna, are designed to target the initial coronavirus strain and the BA.1 Omicron subvariant. It is also expected to be effective against the prevailing BA.5 type.

A panel of experts at the health ministry on Monday cleared the use of the vaccines. This comes after Pfizer and Moderna both applied for authorization in August.

The decision allows people 12 years or older to receive an additional shot of the Pfizer jab, and people 18 or older to get a Moderna booster at least five months after their most recent shots.

The ministry expects around 68.5 million people to be eligible for the Omicron-targeting jab by October.

Elderly people and healthcare workers will be among the first to receive the booster in a campaign set to kick off as early as next Monday. ...continue reading

Source: ANNnewsCH

News On Japan
POPULAR NEWS

Japan is likely to face increasingly long and dangerously hot summers as global temperatures continue to rise, with advanced climate simulations also pointing to more frequent torrential rain, rising seas and accelerating ice loss by the end of the century.

A tropical depression near the Truk Islands is expected to strengthen into a typhoon within 12 hours, but forecasters say it is unlikely to have any direct impact on Japan.

A protest against Prime Minister Sanae Takaichi was held in Tokyo's Shibuya district on July 16 as public concern grew over a bill that would impose criminal penalties for damaging the Japanese flag.

Tobu Railway has introduced walk-through facial recognition ticket gates at Ikebukuro and Kami-Itabashi stations on the Tobu Tojo Line, allowing registered commuters to enter without presenting a ticket or IC card.

A system failure at frozen food giant Nichirei has disrupted shipments and logistics, raising the risk of product shortages and temporary closures at some Kentucky Fried Chicken restaurants while also affecting major supermarket and retail chains.

MEDIA CHANNELS
         

MORE Sci-Tech NEWS

Fires involving lithium-ion batteries, including those used in mobile battery packs, are occurring at a record pace in Japan this year, with 179 incidents reported by the end of May, according to the Tokyo Fire Department.

JAXA successfully landed a small experimental vehicle for a reusable rocket on July 11, marking a step toward technology that could increase the frequency of space launches while helping reduce costs.

Japan is facing renewed questions over how to secure electricity while dealing with mounting nuclear waste, as power demand is expected to rise with the spread of generative AI and the government considers replacing as many as five nuclear reactors by the 2040s.

JAXA's Hayabusa2 probe made its closest approach to the asteroid Torifune on July 5, passing at high speed about 800 meters from the asteroid's center while conducting a flyby survey to examine its shape and surface materials.

A fossil discovered in Osaka has led to Japan’s first finding of its kind, raising the possibility that a giant marine predator believed to have swum in the seas around the Kansai region about 70 million years ago was a previously unknown species.

Researchers around the world are turning their attention to mitochondria, the energy-producing structures inside cells, as new discoveries suggest they may hold important clues to slowing aging, preventing disease and extending healthy life.

Strong earthquakes have continued to shake parts of Japan in recent weeks, with 11 temblors measuring lower 5 or above on the Japanese seismic intensity scale recorded across the country since April 2026.

Japan is set to begin its first clinical trial of xenotransplantation involving the transplant of pig kidneys into human patients, in a step that could open a new option for people with kidney failure.